Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a full
report of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT03276078” into
the search box, and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D6572C00001” into the search box, and click “Find a Study”.
Full Trial Title: A Phase IIa, Open-Label, Repeat-Dose Clinical Trial to Evaluate
the Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide/Formoterol
Fumarate Fixed Dose Combination Administered Twice-Daily by Inhalation in
Chinese Patients With Moderate to Severe Chronic Obstructive Pulmonary
Disease
AstraZeneca Protocol Number: D6572C00001
AstraZeneca sponsored this study and has its headquarters at
1800 Concord Pike in Wilmington, Delaware.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research
participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
Version 2.1 2019_06_05 8